Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04609722
Recruitment Status : Recruiting
First Posted : October 30, 2020
Last Update Posted : January 13, 2021
Sponsor:
Information provided by (Responsible Party):
Mürşide Zengin, Adiyaman University Research Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
In this research, it was aimed to determine the anxiety levels of parents in the Covid-19 pandemic and to examine the effects of the Solution-Focused Support Program, which is planned to be given to parents with high anxiety levels.

Condition or disease Intervention/treatment Phase
Anxiety Parents Covid19 Other: Solution-Focused Support Program Not Applicable

Detailed Description:
The study is conducted with parents whose children aged 3-6 years, and have high anxiety levels. In collecting research data; an introductory information form prepared by researchers and the State-Trait Anxiety Inventory will be used.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: Effect of Solution-Focused Support Program on Anxiety Levels of Parents With Children Aged 3-6 Years During the COVID-19 Pandemic
Actual Study Start Date : July 1, 2020
Estimated Primary Completion Date : February 1, 2021
Estimated Study Completion Date : February 15, 2021

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: intervention group
Solution-Focused Support Program will apply to the participants.
 Other: Solution-Focused Support Program
All participants will be given a program of 4 sessions for 4 weeks. Each session is planned to last approximately 50 minutes.
No Intervention: control group
No intervention will be applied to the parents in the control group.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. State-Trait Anxiety Inventory (STAI) [ Time Frame: 5 minutes ]
    STAI was developed by Spielberg et al. In 1970 to measure the trait and state anxiety levels of individuals and was adapted to Turkish by Öner and Le Compte (1983) (Gilik and Avşaroğlu 2017). There are a total of 40 questions in the State-Trait Anxiety Scale. The State Anxiety Sub-Scale (STAI-S) evaluates how an individual feels at a particular time and under certain conditions. The Trait Anxiety Subscale (STAI-T) generally assesses how an individual feels. The scores obtained from both scales vary between 20 and 80. High score indicates high anxiety level, low score indicates low anxiety level.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Parents with children aged 3-6,
  • Having internet at home or mobile phone,
  • Parents who volunteer to participate in the study

Exclusion Criteria:

  • Having communication problems,
  • Parents who have not attended at least one session
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04609722


Contacts
Layout table for location contacts
Contact: Mürşide .zengin +905456801901 mzengin@adiyaman.edu.tr

Locations
Layout table for location information
Turkey
Online- Data will be collected through the form created with the Google-Forms Recruiting
Adıyaman, Turkey, 02100
Contact: Ceyda Başoğul, PhD    +90 416 2233800    ceydayk@hotmail.com   
Sponsors and Collaborators
Adiyaman University Research Hospital
Investigators
Layout table for investigator information
Principal Investigator: Ceyda Başoğul Adiyaman University
Principal Investigator: Emriye Hilal Yayan İnönü University
Principal Investigator: Mürşide Zengin Adiyaman University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Mürşide Zengin, Adıyaman University, Adiyaman University Research Hospital
ClinicalTrials.gov Identifier: NCT04609722    
Other Study ID Numbers: 2020/751
First Posted: October 30, 2020    Key Record Dates
Last Update Posted: January 13, 2021
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mürşide Zengin, Adiyaman University Research Hospital:
anxiety
child
nursing practice
parents
Solution-Focused Support Program
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Anxiety Disorders
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
 Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases
Mental Disorders